Home » Topics » Conferences

Conferences
RSS

Novel immunosuppressive mechanism described for FR-167653

Dec. 9, 1999

Role of MAPK pathway in the anticancer activity of farnesyltransferase inhibitors

Dec. 9, 1999

Hughes Institute presents new anticancer compounds at two recent congresses

Dec. 9, 1999

Teijin's activated protein C concentrate described to ASH participants

Dec. 9, 1999

ASH meeting news: early clinical data presented on novel anticoagulant from SmithKline Beecham

Dec. 9, 1999

Tokyo-based research team designs new carborane-containing estrogen receptor modulators

Dec. 9, 1999

Hughes team reports advances in anti-HIV drug development

Dec. 9, 1999

Early indications of therapeutic benefit with Coagulin-B

Dec. 8, 1999

Novartis reports setbacks and advances in the development of new chelating agents

Dec. 8, 1999

Hughes Institute team describes research into platinum complexes

Dec. 8, 1999

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...